Pfizer have dangled peanuts, some RAP shareholders short sighted monkeys., page-32

"Medical companies aren't going to just sign up/purchase software just because it's on the apple store" – nobody is suggesting that, not even @nippy in that post. You read "app store" when nippy wrote "putting it into their apps".

"Even at small scale these things take time" – your post indicates you're a long, long way behind the game in your knowledge of this company and you should do some catching up before you start giving us the benefit of your views. You may be wise and intelligent but at present you're uninformed.

The facts are that it has taken time and the company has been engaged for years doing exactly what you said: engaging face to face, conducting commercial integration pilot projects, demonstrating the efficacy, and so on. And this work has borne fruit. Medical companies are signing up, and integrating ResappDx into their platforms, and rolling out the diagnosis as a service.

"wouldn't the testing be required to be undertaken in conjunction with a medical professional" – again, your serious lack of knowledge is on show about how the product is positioned. This is a diagnostic test. Only a medical practitioner is in a position to determine what is an appropriate and safe treatment. The company has never said otherwise.